{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:15:22Z","timestamp":1760058922861,"version":"build-2065373602"},"reference-count":63,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T00:00:00Z","timestamp":1746921600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biology"],"abstract":"<jats:p>Bisphosphonates (BPs) are drugs used to cure metabolic diseases like osteoporosis and oncological conditions, such as multiple myeloma and bone metastases. The pharmacological activity of these compounds is mediated by their capacity to induce a systemic osteoclast depletion, finally resulting in reduced bone resorption. In spite of their efficacy, the clinical application of BPs is sometimes associated with a frightening side effect known as osteonecrosis of the jaw (ONJ). In principle, a therapeutic approach able to elicit the local re-activation of osteoclast production could counteract the onset of ONJ and promote the healing of its lesions. Using a vitamin D3-dependent model of osteoclast differentiation, it has been previously demonstrated that when used at supra-physiological concentrations, magnesium strongly favors the process under consideration, and its effect is furtherly enhanced by the presence of a BP called zoledronate. Here, we show that similar results can be obtained in a RANKL-dependent model of osteoclast differentiation, suggesting that a topical therapy based on magnesium may be also suitable for ONJ determined by denosumab in light of the ability of this monoclonal antibody to target RANKL.<\/jats:p>","DOI":"10.3390\/biology14050533","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T12:18:06Z","timestamp":1747052286000},"page":"533","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Supra-Physiological Levels of Magnesium Counteract the Inhibitory Effect of Zoledronate on RANKL-Dependent Osteoclastogenesis"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1401-0381","authenticated-orcid":false,"given":"Lorenzo","family":"Caselli","sequence":"first","affiliation":[{"name":"Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"De Pasquale","sequence":"additional","affiliation":[{"name":"Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rossella","family":"Palumbo","sequence":"additional","affiliation":[{"name":"Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1296-4718","authenticated-orcid":false,"given":"Silvia","family":"Ricchiuto","sequence":"additional","affiliation":[{"name":"Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Montanari","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2496-4181","authenticated-orcid":false,"given":"Sebastiano","family":"Rontauroli","sequence":"additional","affiliation":[{"name":"Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Ottani","sequence":"additional","affiliation":[{"name":"Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruggiero","family":"Norfo","sequence":"additional","affiliation":[{"name":"Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9911-7078","authenticated-orcid":false,"given":"Tommaso","family":"Zanocco-Marani","sequence":"additional","affiliation":[{"name":"Department of Life Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3319-1707","authenticated-orcid":false,"given":"Alexis","family":"Grande","sequence":"additional","affiliation":[{"name":"Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,5,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1097\/PRS.0b013e31824eca94","article-title":"Bone biology and physiology: Part I. The fundamentals","volume":"129","author":"Buck","year":"2012","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0004563218759371","article-title":"The bone remodelling cycle","volume":"55","author":"Kenkre","year":"2018","journal-title":"Ann. Clin. Biochem."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"950e","DOI":"10.1097\/PRS.0b013e31824ec354","article-title":"Bone biology and physiology: Part II. Clinical correlates","volume":"129","author":"Buck","year":"2012","journal-title":"Plast. Reconstr. Surg."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pop.2024.04.005","article-title":"Metabolic Bone Disease","volume":"51","author":"Seemann","year":"2024","journal-title":"Prim. Care"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Yang, C., Tian, Y., Zhao, F., Chen, Z., Su, P., Li, Y., and Qian, A. (2020). Bone Microenvironment and Osteosarcoma Metastasis. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21196985"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","article-title":"Bone metastases","volume":"6","author":"Coleman","year":"2020","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Bernstein, Z.S., Kim, E.B., and Raje, N. (2022). Bone Disease in Multiple Myeloma: Biologic and Clinical Implications. Cells, 11.","DOI":"10.3390\/cells11152308"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11914-017-0397-5","article-title":"Myeloma and Bone Disease","volume":"15","author":"Panaroni","year":"2017","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1111\/bcp.13867","article-title":"Pharmacology of Bisphosphonates","volume":"85","author":"Cremers","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1345\/aph.1M102","article-title":"Denosumab in osteoporosis and oncology","volume":"43","author":"Burkiewicz","year":"2009","journal-title":"Ann. Pharmacother."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1111\/bcp.13866","article-title":"The skeletal impact of cancer therapies","volume":"85","author":"Bedatsova","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1177\/154405910708601102","article-title":"Mechanism of Action, Pharmacokinetic and Pharmacodynamic Profile, and Clinical Applications of Nitrogen-Containing Bisphosphonates","volume":"86","author":"Kimmel","year":"2007","journal-title":"J. Dent. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and Zoledronate (Zometa) Induced Avascular Necrosis of the Jaws: A Growing Epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40729-021-00323-0","article-title":"Clinical Considerations for Medication-Related Osteonecrosis of the Jaw: A Comprehensive Literature Review","volume":"7","author":"Kawahara","year":"2021","journal-title":"Int. J. Implant. Dent."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.joms.2022.02.008","article-title":"American Association of Oral and Maxillofacial Surgeons\u2019 Position Paper on Medication-Related Osteonecrosis of the Jaws\u20142022 Update","volume":"80","author":"Ruggiero","year":"2022","journal-title":"J. Oral Maxillofac. Surg."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.coms.2015.06.001","article-title":"Pathophysiology of Osteonecrosis of the Jaws","volume":"27","author":"Aghaloo","year":"2015","journal-title":"Oral Maxillofac. Surg. Clin. N. Am."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/s11914-018-0474-4","article-title":"Current Understanding of the Pathophysiology of Osteonecrosis of the Jaw","volume":"16","author":"Chang","year":"2018","journal-title":"Curr. Osteoporos. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Anesi, A., Generali, L., Sandoni, L., Pozzi, S., and Grande, A. (2019). From Osteoclast Differentiation to Osteonecrosis of the Jaw: Molecular and Clinical Insights. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20194925"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.jcms.2015.03.039","article-title":"Tooth Extraction in Patients Receiving Oral or Intravenous Bisphosphonate Administration: A Trigger for BRONJ Development?","volume":"43","author":"Otto","year":"2015","journal-title":"J. Craniomaxillofac. Surg."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.ijom.2012.06.020","article-title":"Increased Incidence of Osteonecrosis of the Jaw after Tooth Extraction in Patients Treated with Bisphosphonates: A Cohort Study","volume":"41","author":"Yamazaki","year":"2012","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"10867","DOI":"10.1021\/acs.jmedchem.9b01405","article-title":"Farnesyl Pyrophosphate Synthase as a Target for Drug Development: Discovery of Natural-Product-Derived Inhibitors and Their Activity in Pancreatic Cancer Cells","volume":"62","author":"Han","year":"2019","journal-title":"J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Fu, P.A., Shen, C.Y., Yang, S.R., Lee, C.H., Chen, H.W., Lai, E.C., and Chung, W.P. (2023). Long-term use of denosumab and its association with skeletal-related events and osteonecrosis of the jaw. Sci. Rep., 13.","DOI":"10.1038\/s41598-023-35308-z"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s00520-020-05855-6","article-title":"Differences between bisphosphonate-related and denosumab-related osteonecrosis of the jaws: A systematic review","volume":"29","author":"Querrer","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Eleutherakis-Papaiakovou, E., and Bamias, A. (2017). Antiresorptive treatment-associated ONJ. Eur. J. Cancer Care, 26.","DOI":"10.1111\/ecc.12787"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.oraloncology.2014.08.016","article-title":"A Systematic Review of Therapeutical Approaches in Bisphosphonates-Related Osteonecrosis of the Jaw (BRONJ)","volume":"50","author":"Rupel","year":"2014","journal-title":"Oral Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijom.2015.01.026","article-title":"Treatment Strategies and Outcomes of Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) with Characterization of Patients: A Systematic Review","volume":"44","author":"Fliefel","year":"2015","journal-title":"Int. J. Oral Maxillofac. Surg."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00198-015-3335-3","article-title":"Osteonecrosis of the Jaw (ONJ): Diagnosis and Management in 2015","volume":"27","author":"Khan","year":"2016","journal-title":"Osteoporos. Int."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1002\/jbmr.3191","article-title":"Evaluation of the Treatment Strategies for Medication-Related Osteonecrosis of the Jaws (MRONJ) and the Factors Affecting Treatment Outcome: A Multicenter Retrospective Study with Propensity Score Matching Analysis","volume":"32","author":"Hayashida","year":"2017","journal-title":"J. Bone Miner. Res."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Zanocco-Marani, T., Ricchiuto, S., Caselli, L., Lorenzi, E., Lettucci, E., and Grande, A. (2024). Local re-activation of osteoclast differentiation as a novel therapeutic strategy for osteonecrosis of the jaw. Front. Endocrinol., 15.","DOI":"10.3389\/fendo.2024.1447314"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Kwon, Y.D., and Kim, D.Y. (2016). Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ). Dent. J., 4.","DOI":"10.3390\/dj4040041"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Wong, S.K. (2024). Glycogen Synthase Kinase-3 Beta (GSK3\u03b2) as a Potential Drug Target in Regulating Osteoclastogenesis: An Updated Review on Current Evidence. Biomolecules, 14.","DOI":"10.3390\/biom14040502"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s10006-021-00982-8","article-title":"Geranyl-geraniol addition affects potency of bisphosphonates-a comparison in vitro promising a therapeutic approach for bisphosphonate-associated osteonecrosis of the jaw and oral wound healing","volume":"26","author":"Otto","year":"2022","journal-title":"Oral Maxillofac. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Ricchiuto, S., Palumbo, R., Lami, F., Gavioli, F., Caselli, L., Montanari, M., Zappavigna, V., Anesi, A., Zanocco-Marani, T., and Grande, A. (2023). The Capacity of Magnesium to Induce Osteoclast Differentiation Is Greatly Enhanced by the Presence of Zoledronate. Biology, 12.","DOI":"10.20944\/preprints202308.1247.v1"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/07315724.2009.10719764","article-title":"Skeletal and hormonal effects of magnesium deficiency","volume":"28","author":"Rude","year":"2009","journal-title":"J. Am. Coll. Nutr."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.jnutbio.2012.12.008","article-title":"Magnesium deficiency results in an increased formation of osteoclasts","volume":"24","author":"Belluci","year":"2013","journal-title":"J. Nutr. Biochem."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Belluci, M.M., de Molon, R.S., Rossa, C., Tetradis, S., Giro, G., Cerri, P.S., Marcantonio, E., and Orrico, S.R.P. (2020). Severe magnesium deficiency compromises systemic bone mineral density and aggravates inflammatory bone resorption. J. Nutr. Biochem., 77.","DOI":"10.1016\/j.jnutbio.2019.108301"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jot.2022.03.004","article-title":"Biodegradable magnesium implant enhances angiogenesis and alleviates medication-related osteonecrosis of the jaw in rats","volume":"33","author":"Zhu","year":"2022","journal-title":"J. Orthop. Translat."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Zheng, L.Z., Wang, J.L., Xu, J.K., Zhang, X.T., Liu, B.Y., Huang, L., Zhang, R., Zu, H.Y., He, X., and Mi, J. (2020). Magnesium and vitamin C supplementation attenuates steroid-associated osteonecrosis in a rat model. Biomaterials, 238.","DOI":"10.1016\/j.biomaterials.2020.119828"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Mammoli, F., Castiglioni, S., Parenti, S., Cappadone, C., Farruggia, G., Iotti, S., Davalli, P., Maier, J., Grande, A., and Frassineti, C. (2019). Magnesium Is a Key Regulator of the Balance between Osteoclast and Osteoblast Differentiation in the Presence of Vitamin D3. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20020385"},{"key":"ref_40","first-page":"114","article-title":"Magnesium Favors the Capacity of Vitamin D3 to Induce the Monocyte Differentiation of U937 Cells","volume":"34","author":"Parenti","year":"2021","journal-title":"Magnes. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.actbio.2015.08.042","article-title":"Effects of Extracellular Magnesium Extract on the Proliferation and Differentiation of Human Osteoblasts and Osteoclasts in Coculture","volume":"27","author":"Wu","year":"2015","journal-title":"Acta Biomater."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6299","DOI":"10.1016\/j.biomaterials.2014.04.044","article-title":"The effect of metallic magnesium degradation products on osteoclast-induced osteolysis and attenuation of NF-\u03baB and NFATc1 signaling","volume":"35","author":"Zhai","year":"2014","journal-title":"Biomaterials"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1016\/j.actbio.2014.02.010","article-title":"Effects of extracellular magnesium on the differentiation and function of human osteoclasts","volume":"10","author":"Wu","year":"2014","journal-title":"Acta Biomater."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0026-0495(83)90224-X","article-title":"Effects of magnesium and lactose supplementation on bone metabolism in the X-linked hypophosphatemic mouse","volume":"32","author":"Marie","year":"1983","journal-title":"Metabolism"},{"key":"ref_45","first-page":"281","article-title":"Relation of magnesium to osteoporosis and calcium urolithiasis","volume":"10","author":"Wallach","year":"1991","journal-title":"Magnes. Trace Elem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s12011-009-8416-8","article-title":"Short-term oral magnesium supplementation suppresses bone turnover in postmenopausal osteoporotic women","volume":"133","author":"Aydin","year":"2010","journal-title":"Biol. Trace Elem. Res."},{"key":"ref_47","first-page":"2742","article-title":"Daily oral magnesium supplementation suppresses bone turnover in young adult males","volume":"83","author":"Dimai","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_48","first-page":"227","article-title":"Magnesium supplementation and bone turnover","volume":"57","author":"Martini","year":"1999","journal-title":"Nutr. Rev."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.nutres.2022.12.005","article-title":"Combined vitamin D and magnesium supplementation does not influence markers of bone turnover or glycemic control: A randomized controlled clinical trial","volume":"110","author":"Dall","year":"2023","journal-title":"Nutr. Res."},{"key":"ref_50","first-page":"126","article-title":"Dietary magnesium supplementation suppresses bone resorption via inhibition of parathyroid hormone secretion in rats fed a high-phosphorus diet","volume":"23","author":"Matsuzaki","year":"2010","journal-title":"Magnes. Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/BF02405119","article-title":"Influence of magnesium supplementation on bone turnover in the normal young mouse","volume":"35","author":"Marie","year":"1983","journal-title":"Calcif. Tissue Int."},{"key":"ref_52","first-page":"100","article-title":"Effect of calcitonin on the magnesium-induced bone resorption in the mouse","volume":"6","author":"Marie","year":"1987","journal-title":"Magnesium"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"8380","DOI":"10.3892\/mmr.2017.7625","article-title":"High-dose PMA with RANKL and MCSF induces THP-1 cell differentiation into human functional osteoclasts in vitro","volume":"16","author":"Li","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.bone.2006.09.023","article-title":"The Molecular Understanding of Osteoclast Differentiation","volume":"40","author":"Asagiri","year":"2007","journal-title":"Bone"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast Differentiation and Activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"ref_56","first-page":"1261","article-title":"Autoamplification of NFATc1 Expression Determines Its Essential Role in Bone Homeostasis","volume":"202","author":"Asagiri","year":"2005","journal-title":"Exp. Biol. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2302\/kjm.60.101","article-title":"Regulators of Osteoclast Differentiation and Cell-Cell Fusion","volume":"60","author":"Miyamoto","year":"2011","journal-title":"Keio J. Med."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s13058-018-1076-x","article-title":"CD68, CD163, and Matrix Metalloproteinase 9 (MMP-9) Co-Localization in Breast Tumor Microenvironment Predicts Survival Differently in ER-Positive and -Negative Cancers","volume":"20","author":"Pelekanou","year":"2018","journal-title":"Breast Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1046\/j.1365-2141.1999.01491.x","article-title":"Human osteoclasts derive from CD14-positive monocytes","volume":"106","author":"Massey","year":"1999","journal-title":"Br. J. Haematol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"4435","DOI":"10.1182\/bloodadvances.2021004552","article-title":"Novel population of human monocyte and osteoclast progenitors from pluripotent stem cells and peripheral blood","volume":"5","author":"Root","year":"2021","journal-title":"Blood Adv."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00784-014-1273-7","article-title":"Macrophages and bisphosphonate-related osteonecrosis of the jaw (BRONJ): Evidence of local immunosuppression of macrophages in contrast to other infectious jaw diseases","volume":"19","author":"Hoefert","year":"2015","journal-title":"Clin. Oral Investig."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"116899","DOI":"10.1016\/j.bone.2023.116899","article-title":"Depletion of macrophages deteriorates bisphosphonate-related osteonecrosis of the jaw-like lesions in mice","volume":"177","author":"Kozutsumi","year":"2023","journal-title":"Bone"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Gkouveris, I., Soundia, A., Gouveris, P., Zouki, D., Hadaya, D., and Tetradis, S. (2022). Macrophage Involvement in Medication-Related Osteonecrosis of the Jaw (MRONJ): A Comprehensive, Short Review. Cancers, 14.","DOI":"10.3390\/cancers14020330"}],"container-title":["Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-7737\/14\/5\/533\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:30:56Z","timestamp":1760031056000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-7737\/14\/5\/533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,11]]},"references-count":63,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["biology14050533"],"URL":"https:\/\/doi.org\/10.3390\/biology14050533","relation":{},"ISSN":["2079-7737"],"issn-type":[{"type":"electronic","value":"2079-7737"}],"subject":[],"published":{"date-parts":[[2025,5,11]]}}}